National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

CONFERENCE DATES > Thursday, March 23 – Saturday, March 25, 2017      LEARN MORE>

CONFERENCE LOCATION > Rosen Shingle Creek • Orlando, Florida

Additional Conference Programs:

NCCN ACADEMY > Wednesday, March 22, 2017          LEARN MORE >

NCCN 2017 NURSING PROGRAM > Wednesday, March 22, 2017              LEARN MORE >
The Nursing Program has reached maximum capacity. All registrants from this point on will be placed on a wait-list and will be contacted if a seat becomes available. We encourage you to register and attend the main conference.

OVERVIEW

The NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ attracts more than 1,600 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

This conference (with the exception of the NCCN Roundtable Discussion) has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals. NCCN will also seek approval for case manager and tumor registrar clock hours.

AGENDA*

This year’s conference includes more than 20 educational sessions featuring the latest advances in oncology care, including interactive patient case studies.

Topic areas include:

  • Breast Cancer
  • Gynecologic Cancers
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Lung Cancers
  • Hematologic Malignancies
  • Cancer Risk Reduction
  • Survivorship
  • Supportive Care
  • Other Tumors/Topics Across Diseases

 

Thursday, March 23, 2017

7:00 - 8:00 AM


Breakfast, Exhibits, and General Poster Session (Exhibition Hall)


8:00 - 8:10 AM

Welcome and Opening Remarks

Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network


8:15 - 9:30 AM

NCCN Roundtable Discussion:
Emerging Issues in Oncology – 
Addressing Health Disparities in Cancer Care from Diagnosis to Survivorship

Moderator: Clifford Goodman, PhD, Senior Vice President, The Lewin Group

Panelists: Shauntice Allen, PhD
University of Alabama at Birmingham Comprehensive Cancer Center

Moon S. Chen, Jr., PhD, MPH
University of California Davis Comprehensive Cancer Center

Anne Filipic
​Enroll America

Edith Mitchell, MD
​Sidney Kimmel Cancer Center at Jefferson

Phyllis Pettit Nassi, MSW
Huntsman Cancer Institute at the University of Utah

This non-accredited roundtable will provide an opportunity for a varied group of stakeholders including providers, payers, patient advocates, industry, and government to discuss disparities in cancer care among minorities and medically underserved populations.

This roundtable is supported by Astellas; Taiho Oncology; and Janssen Oncology, a Pharmaceutical Company of Johnson & Johnson. Sponsored by AbbVie and Novartis. Supported by an educational grant from Agios and Takeda Oncology. Supported by an educational donation provided by Amgen. Sponsored by a financial contribution from Bristol-Myers Squibb. Supported by an unrestricted grant from Eisai Inc. This activity is supported by a contribution from Lilly. This activity was made possible by Pharmacyclics LLC and Janssen Biotech, Inc.

 

9:30 - 9:50 AM


Break, Exhibits, and General Poster Session (Exhibition Hall)


9:50 - 10:35 AM

New Treatment Guidelines for Myeloproliferative Neoplasms and Myelofibrosis

Ruben A. Mesa, MD
Mayo Clinic Cancer Center


10:40 - 11:25 AM

Evolving Treatment of Soft Tissue Sarcoma

Suzanne George, MD
Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center


11:30 AM -12:15 PM

Multi-Gene Testing for Hereditary Cancer: When, Why, and How?

Kenneth Offit, MD
Memorial Sloan Kettering Cancer Center


12:15 - 1:45 PM


Lunch, Exhibits, and General Poster Session (Exhibition Hall)


1:45 - 3:15 PM

NCCN Guidelines® Updates: Non-Small Cell Lung Cancer

What, When, and How of Biomarker Testing in Non-Small Cell Lung Cancer

Gregory J. Riely, MD, PhD
Memorial Sloan Kettering Cancer Center

Biomarker-based Treatment Selection in Non-Small Cell Lung Cancer

Wallace Akerley, MD
Huntsman Cancer Institute at the University of Utah

Immunotherapies for Lung Cancer

Matthew A. Gubens, MD, MS
UCSF Helen Diller Family Comprehensive Cancer Center


3:15 - 3:40 PM


Break, Exhibits, and General Poster Session (Exhibition Hall)


3:40 - 4:25 PM

Incorporating New Systemic Therapies in Kidney Cancer Treatment

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center


4:30 – 5:15 PM

Challenges of Toxicity Management in Immuno-oncology

Stephanie Andrews, MS, ANP-BC
Moffitt Cancer Center


5:15 - 5:30 PM


Free Time


5:30 - 7:30 PM


Welcome Reception (Exhibition Hall)
Kids Movie Night (Gatlin A1 & A2)



Friday, March 24, 2017

7:00 - 8:00 AM


Breakfast, Exhibits, and General Poster Session (Exhibition Hall)

Breakfast Symposium§ 7:00 – 8:00 AM

Expert Guidance for Optimizing Immune Checkpoint Inhibitor Therapy for Kidney and Bladder Cancer

Jointly sponsored by NCCN and Clinical Care Options, LLC.

This activity is supported by educational grants from AstraZeneca and Genentech; an independent medical education grant from Bristol-Myers Squibb; and an independent educational grant from Merck Co, Inc.

 

8:00 - 8:10 AM


Opening Remarks


8:15 - 9:30 AM


Keynote Address:
When Breath Becomes Air – As Physician Becomes Patient

Lucy Kalanithi, MD
Widow of the late Dr. Paul Kalanithi, author of the #1 New York Times bestselling memoir, When Breath Becomes Air, for which she wrote the epilogue; Clinical Assistant Professor of Medicine, Stanford School of Medicine

Heather Wakelee, MD
Associate Professor of Medicine, Stanford Cancer Institute;
Treating Oncologist of the late Dr. Paul Kalanithi 

This keynote will provide an opportunity to discuss key inflection points during the course of a life-threatening illness and how they contribute to the complexity of relationships among patients, their families, and their health care professionals. Strategies to optimize communication between clinician-patient-family during the course of a life-threatening illness as well  as key factors to consider in developing an individual approach to clinician-patient-family communication to ensure  optimal care and informed decision-making will also be addressed.


9:30 - 9:55 AM


Break, Exhibits, and General Poster Session (Exhibition Hall)


9:55 - 10:40 AM

Opportunities and Challenges: Human Papillomavirus and Cancer

Christina S. Chu, MD
Fox Chase Cancer Center

David G. Pfister, MD
Memorial Sloan Kettering Cancer Center


10:45 AM - 12:15 PM


NCCN Guidelines® Updates: Breast Cancer 

Evolving Radiation Therapy Recommendations for Breast Cancer

Kilian E. Salerno, MD
Roswell Park Cancer Institute

Use of Biomarkers and Multigene Assays in Breast Cancer

Lee S. Schwartzberg, MD
The University of Tennessee Health Science Center

New Approaches to Endocrine Therapy for Breast Cancer

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University


12:15 - 1:45 PM


Lunch, Exhibits, and General Poster Session (Exhibition Hall)


12:25 – 1:40 PM

Lunch Symposium§ 12:25 – 1:40 PM
Examining Health Policy, Payer, Provider, and Patient Perspectives in Indolent Non-Hodgkin's Lymphomas

Presented by NCCN and PRIME® Education, LLC.

There is no fee for this activity as it is sponsored by PRIME through educational grants from AbbVie, Inc and Gilead Sciences, Inc.


1:45 - 2:30 PM


Smoking Cessation in Patients with Cancer: Treatment Advances and the Oncologist’s Role

Paul M. Cinciripini, PhD
The University of Texas MD Anderson Cancer Center


2:35 - 3:20 PM


Novel Treatment Options for Neuroendocrine Tumors

Matthew H. Kulke, MD, MMSc
Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center


3:20 - 3:40 PM


Break and Exhibits (Exhibition Hall)


3:40 - 4:25 PM


New Options in the Management of Multiple Myeloma

Shaji K. Kumar, MD
Mayo Clinic Cancer Center


4:30 - 5:15 PM


Updates to the Management of Advanced Bladder Cancer

Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center


5:30 - 7:15 PM

Dinner Symposium§ 6:00 – 7:15 PM

Insights on Individualizing Treatment of Patients with Multiple Myeloma

Presented by NCCN.

This activity is supported by educational funding provided by Amgen and educational grants from Celgene Corporation and Janssen Biotech, Inc.




Saturday, March 25, 2017

7:00 - 8:00 AM


Breakfast (Gatlin Ballroom Foyer)


8:00 - 8:10 AM


Opening Remarks


8:15 - 9:00 AM


Minimally Invasive Techniques for Treating Gynecologic Malignancies

Amanda Nickles Fader, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


9:05 - 9:50 AM


Chronic Lymphocytic Leukemia: Individualizing Treatment Approach

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center


9:50 - 10:10 AM


Break (Gatlin Ballroom Foyer)


10:10 - 10:55 AM


Active Systemic Treatment of Pancreatic Cancer

Margaret A. Tempero, MD
UCSF Helen Diller Family Comprehensive Cancer Center


11:00 - 11:45 AM


Implications of the New AJCC Staging System

Stephen B. Edge, MD
Roswell Park Cancer Institute


11:45 - 12:30 PM


Lunch (Gatlin Ballroom Foyer)


12:30 - 1:15 PM


Life After Treatment: Quality of Life Concerns in Patients Treated for Cancer

Mindy E. Goldman, MD
UCSF Helen Diller Family Comprehensive Cancer Center


1:20 - 2:05 PM


Strategies for Management of Relapsed/Refractory Hodgkin Lymphoma

Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University


2:10 - 2:55 PM


Systemic Management of Colorectal Cancer

Wells Messersmith, MD
University of Colorado Cancer Center


2:55 - 3:00 PM


Closing Remarks


§ These symposia are open to all health care providers attending the conference; pre-registration is not required. CME/CNE/CPE available. The symposia are accredited and supported separately from all other educational sessions on this agenda. Seating is limited and on a first-come, first-seated basis.


INTENDED AUDIENCE

This conference is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

ACCREDITATION INFORMATION

This conference (with the exception of the NCCN Roundtable Discussion) has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals. NCCN will also seek approval for case manager and tumor registrar clock hours.

SUPPORTERS

This conference is supported by educational grants from Ariad; Astellas and Medivation, Inc.; AstraZeneca; BTG International Inc.; Celgene Corporation; Celldex Therapeutics; Foundation Medicine; Genentech; Genomic Health, Inc.; Gilead Sciences, Medical Affairs; Lilly; Merrimack Pharmaceuticals, Inc.; Novartis; Pfizer; Prometheus Laboratories Inc.; Taiho Oncology; and Takeda Oncology. This activity is supported by independent educational grants from AbbVie; Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte; and Merck Co., Inc. This activity is supported by educational funding provided by Amgen. This educational activity is supported by a medical education grant from Exelixis, Inc.

As of March 20, 2017

Organizations who are interested in supporting NCCN CE programs are encouraged to contact Lisa Perfidio.

FEE INFORMATION

Click here for fee information.

ACCOMMODATIONS

ATTENTION:  The online room request is no longer an option.  Please contact Diane McPherson at McPherson@nccn.org for information.


EXHIBITOR INFORMATION

NCCN 22nd Annual Conference: Show Services Kit

NCCN 22nd Annual Conference: Exhibition Guide

NCCN 22nd Annual Conference: Sponsor & Exhibitor Prospectus

NCCN 22nd Annual Conference: Advertising Rate Card


FUTURE NCCN ANNUAL CONFERENCE DATES

  • March 22 – 24, 2018
    NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™
    Rosen Shingle Creek, Orlando, FL
    Pre-conference programs take place on March 21, 2018

  • March 21 – 23, 2019
    NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™
    Rosen Shingle Creek, Orlando, FL
    Pre-conference programs take place on March 20, 2019

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.